ArticleStem cell research & therapy2020

Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells.

Zhu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.